Boston, MA. Nixon Peabody LLP represented Health Catalyst, a leading provider of data and analytics technology and services to healthcare organizations, in its acquisition of tech-enabled cybersecurity provider Intraprise Health, LLC.
Intraprise offers an end-to-end cybersecurity risk management platform and related services to protect clients from cyberattacks and manage follow-on liability in the event of an incident. Health Catalyst anticipates that Intraprise will enhance the company’s offerings by advancing information security strategy and risk data management to incorporate industry security standards and protocols.
Health Catalyst funded the transaction with a mix of cash and stock.
“This acquisition reinforces the critical nature of managing data privacy- and cybersecurity-related risks across the healthcare industry—and the need to stay in front of those risks,” said Nixon Peabody Corporate partner Amy O’Keefe, who led the firm’s deal team. “It was a privilege to work on this transaction with such smart, practical, and kind humans on all sides of the deal-making table.”
Read Health Catalyst’s press release here to learn more about the companies.
In addition to O’Keefe, the Nixon Peabody team included partners Gregory O’Shaughnessy, Jeffrey Gilbreth, Thomas McCord, Shahzad Malik, April Schweitzer, Jenny Holmes, Andrew Share, Alexandra Lopez-Casero, Richard Langan, and Rebecca Simone; counsel David Crosby and Jason Kunze; senior attorney Shelagh Michaud; and associates Anthony Bova, Mukta Chilakamarri, Ryan Cosmopulos, Brian Kenney, Matthew Morris, Emily Morrison, and Dave Zimmermann.
